Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 24 | $4,559,125 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Dec 2022 21:44 | ENTA | ENANTA PHARMACEUTICALS INC | LULY JAY R. | President and CEO | 16 Dec 2022 | Sale | 13,603 | 45.49 | 618,800 | D |
16 Dec 2022 21:44 | ENTA | ENANTA PHARMACEUTICALS INC | LULY JAY R. | President and CEO | 16 Dec 2022 | Sale | 8,597 | 44.54 | 382,910 | D |
16 Dec 2022 21:44 | ENTA | ENANTA PHARMACEUTICALS INC | LULY JAY R. | President and CEO | 16 Dec 2022 | Sale | 7,800 | 43.59 | 340,002 | D |
13 Feb 2023 19:58 | ENTA | ENANTA PHARMACEUTICALS INC | MELLETT PAUL J | Treasurer and CFO | 09 Feb 2023 | Sale | 800 | 54.41 | 43,528 | D |
13 Feb 2023 19:58 | ENTA | ENANTA PHARMACEUTICALS INC | MELLETT PAUL J | Treasurer and CFO | 09 Feb 2023 | Sale | 4,200 | 53.64 | 225,288 | D |
14 Mar 2023 18:26 | ENTA | ENANTA PHARMACEUTICALS INC | LULY JAY R. | President and CEO | 13 Mar 2023 | Sale | 1,566 | 46.13 | 72,240 | D |
14 Mar 2023 18:26 | ENTA | ENANTA PHARMACEUTICALS INC | LULY JAY R. | President and CEO | 13 Mar 2023 | Sale | 15,649 | 45.31 | 709,056 | D |
14 Mar 2023 18:26 | ENTA | ENANTA PHARMACEUTICALS INC | LULY JAY R. | President and CEO | 13 Mar 2023 | Sale | 10,697 | 44.81 | 479,333 | D |
17 Mar 2023 18:41 | ENTA | ENANTA PHARMACEUTICALS INC | MELLETT PAUL J | Treasurer and CFO | 15 Mar 2023 | Sale | 10,340 | 44.43 | 459,406 | D |
17 Mar 2023 18:41 | ENTA | ENANTA PHARMACEUTICALS INC | MELLETT PAUL J | Treasurer and CFO | 15 Mar 2023 | Sale | 100 | 43.96 | 4,396 | D |
17 Mar 2023 18:37 | ENTA | ENANTA PHARMACEUTICALS INC | OR YAT SUN | Sr. VP & CSO | 15 Mar 2023 | Sale | 13,656 | 44.46 | 607,146 | D |
17 Mar 2023 18:37 | ENTA | ENANTA PHARMACEUTICALS INC | OR YAT SUN | Sr. VP & CSO | 15 Mar 2023 | Sale | 269 | 43.92 | 11,814 | D |
06 Dec 2023 20:31 | ENTA | ENANTA PHARMACEUTICALS INC | LUU BRENDAN | Sr. VP, Business Dev. | 05 Dec 2023 | Sale | 2,125 | 9.63 | 20,464 | D |
06 Dec 2023 20:26 | ENTA | ENANTA PHARMACEUTICALS INC | GARDINER NATHANIEL S. | Sr. VP & General Counsel | 05 Dec 2023 | Sale | 2,412 | 9.63 | 23,228 | D |
06 Dec 2023 20:24 | ENTA | ENANTA PHARMACEUTICALS INC | ROTTINGHAUS SCOTT T. | Sr. VP & CMO | 05 Dec 2023 | Sale | 534 | 9.63 | 5,142 | D |
06 Dec 2023 20:29 | ENTA | ENANTA PHARMACEUTICALS INC | KIEFFER TARA LYNN | Sr. VP, New Prod. Strat. & Dev | 05 Dec 2023 | Sale | 2,125 | 9.63 | 20,464 | D |
06 Dec 2023 20:19 | ENTA | ENANTA PHARMACEUTICALS INC | MELLETT PAUL J | Sr. VP, Finance & Admin. & CFO | 05 Dec 2023 | Sale | 2,412 | 9.63 | 23,228 | D |
06 Dec 2023 20:22 | ENTA | ENANTA PHARMACEUTICALS INC | OR YAT SUN | Sr. VP, R&D & CSO | 05 Dec 2023 | Sale | 2,412 | 9.63 | 23,228 | D |
06 Dec 2023 20:17 | ENTA | ENANTA PHARMACEUTICALS INC | LULY JAY R. | President and CEO | 05 Dec 2023 | Sale | 7,230 | 9.63 | 69,625 | D |
15 Dec 2023 20:08 | ENTA | ENANTA PHARMACEUTICALS INC | VANCE TERRY | Director | 13 Dec 2023 | Sale | 15,295 | 9.12 | 139,490 | D |
17 Jun 2024 20:38 | ENTA | ENANTA PHARMACEUTICALS INC | KIEFFER TARA LYNN | Chief Product Strategy Officer | 17 Jun 2024 | Sale | 7,266 | 12.33 | 89,590 | D |
15 Jul 2024 17:29 | ENTA | ENANTA PHARMACEUTICALS INC | ROTTINGHAUS SCOTT T. | Chief Medical Officer | 11 Jul 2024 | Sale | 4,299 | 15.07 | 64,786 | D |
15 Jul 2024 17:29 | ENTA | ENANTA PHARMACEUTICALS INC | ROTTINGHAUS SCOTT T. | Chief Medical Officer | 12 Jul 2024 | Sale | 2,271 | 15.04 | 34,156 | D |
15 Jul 2024 17:29 | ENTA | ENANTA PHARMACEUTICALS INC | ROTTINGHAUS SCOTT T. | Chief Medical Officer | 15 Jul 2024 | Sale | 5,375 | 17.08 | 91,805 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)